How artificial intelligence (AI) is improving immunotherapy Technology

Researchers at Case Western Reserve University's digital imaging lab are pioneering the use of Artificial Intelligence (AI) to predict the efficacy of chemotherapy and determine which patients will benefit from the immunotherapeutic. This is especially true since roughly 20% of all cancer patients actually benefit from the immunotherapy-- a treatment that utilizes drugs to strengthen the immune system against the fight for cancer, as opposed to chemotherapy which are drugs that directly target the cancer cells. "This is no flash in the pan -- this research really seems to be reflecting something about the very biology of the disease, about which is the more aggressive phenotype, and that's information oncologists do not currently have," said Anant Madabhushi. Technology has always been manipulated to advance healthcare. For this particular study, it's all about teaching a computer to detect the unseen changes in lung cancer CT scans and compare them to the first 2-3 cycles of immunotherapy treatment.